CPA Applauds President Trump’s Executive Order to Restore U.S. Pharmaceutical Manufacturing
President Trump’s Executive Order is a bold, necessary move to rebuild America’s pharmaceutical industry and protect our citizens.
CPA Applauds President Trump for Closing De Minimis Loophole to Chinese Imports
President Trump’s action to close the de minimis loophole for China is a monumental victory for American workers, manufacturers, and national security.
CPA Calls on JPMorgan and Bank of America to Withdraw from CATL IPO
The IPO, widely seen as the first major test of President Trump’s America First Investment Policy (AFIP), directly undermines the President’s February directive to block U.S. investment in companies linked to the Chinese military, human rights abuses, and authoritarian surveillance state.
CPA Supports Strong Action in Section 232 Investigation to Save 250,000 American Jobs in the Timber and Lumber Industry
Foreign imports primarily from Cambodia, Malaysia, Mexico, Thailand, and Vietnam—that are heavily subsidized by China—are destroying American cabinet jobs.
CPA Applauds Commerce Department’s Final Determinations Confirming China’s Rampant Trade Violations in Solar Imports from Southeast Asia
The Department’s decision confirms what CPA has consistently warned: Chinese solar companies have been illegally circumventing U.S. trade laws through Southeast Asian shell operations, flooding the U.S. market with dumped and subsidized products directly harming the domestic solar manufacturing industry.
Americans Are Dangerously Dependent on Foreign-made Generic Drugs. Tariffs Can Fix That.
Tariffs on pharmaceutical companies isn’t just good economic policy — it benefits national security and public health.
CPA Supports Senator Rick Scott’s Legislative Package to Protect American Investors from Chinese Exploitation
This legislative initiative aligns with CPA’s commitment to ensuring that U.S. capital does not inadvertently support adversarial regimes that undermine America’s economic and national security interests.
CPA Responds to Chinese Government Sanctions: “We Won’t Be Deterred”
CPA remains unwavering in our commitment to rebuilding U.S. industry and supporting American workers. China’s latest move only proves that our efforts are making an impact—and we will not back down.
America’s Generic Drug Crisis Demands Investment, Not Dependence
The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on foreign manufacturers for generic drugs is at the center of it.
CPA Applauds President Trump’s “Liberation Day” Tariff Announcement as Essential Reset of Global Trade System
The Trump administration’s decision to impose a permanent 10% baseline tariff on imports from all countries, combined strategically with higher reciprocal tariffs on nations engaging in unfair trade practices, marks a crucial step forward in reindustrializing America and restoring economic strength and security.
